Compounds > 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine
Page last updated: 2024-09-03

1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and quipazine

1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine has been researched along with quipazine in 1 studies

Compound Research Comparison

Studies
(1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine)		Trials
(1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine)		Recent Studies (post-2010)
(1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine)		Studies
(quipazine)		Trials
(quipazine)		Recent Studies (post-2010) (quipazine)
53015658041

Protein Interaction Comparison

ProteinTaxonomy1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine (IC50)quipazine (IC50)
5-hydroxytryptamine receptor 3EHomo sapiens (human)0.0004
5-hydroxytryptamine receptor 3BHomo sapiens (human)0.0004
5-hydroxytryptamine receptor 1AHomo sapiens (human)1.4454
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.47
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)1.4
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)2.7
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0617
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)3.7297
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.0035
5-hydroxytryptamine receptor 3AHomo sapiens (human)0.0004
5-hydroxytryptamine receptor 1DSus scrofa (pig)3.7153
Adenylate cyclase type 5Rattus norvegicus (Norway rat)1.4454
5-hydroxytryptamine receptor 3DHomo sapiens (human)0.0004
5-hydroxytryptamine receptor 2ABos taurus (cattle)3.4674
5-hydroxytryptamine receptor 3CHomo sapiens (human)0.0004
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.0035

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batchelor, R; Buchoux, S; Lorch, M; Windle, CJ1

Other Studies

1 other study(ies) available for 1-(2-(4-aminophenyl)ethyl)-4-(3-trifluoromethylphenyl)piperazine and quipazine

ArticleYear
Cholesterol and lipid phases influence the interactions between serotonin receptor agonists and lipid bilayers.
    The Journal of biological chemistry, 2010, Dec-31, Volume: 285, Issue:53

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Cholesterol; Lipid Bilayers; Lipids; Magnetic Resonance Spectroscopy; Membrane Microdomains; Models, Chemical; Models, Statistical; Piperazines; Quipazine; Receptors, G-Protein-Coupled; Serotonin Receptor Agonists; Temperature

2010